Fibromyalgia
IBS's most frequent travel companion, and another face of a sensitized nervous system.
IBS is one of the most common chronic conditions on Earth, and one of the most dismissed. It is not caused by damage a scope can see, and it is not imaginary. It lives in the conversation between the gut and the nervous system, which is why some of the best-proven treatments work on the brain's side of that conversation.
What is irritable bowel syndrome?
Irritable bowel syndrome (IBS) is a common, real disorder of gut–brain interaction: the gut and nervous system miscommunicate, producing recurrent abdominal pain tied to changes in bowel habits, whether diarrhea, constipation, or both. About 4% of adults worldwide meet strict Rome IV criteria. IBS is diagnosed by its symptom pattern and treated with diet changes, medications, and brain-directed therapies backed by clinical trials.
The old name 'functional bowel disorder' has been retired for a reason: research shows a specific problem, oversensitive gut-brain signaling, rather than an absence of one.
Irritable bowel syndrome is defined by a pattern: recurring abdominal pain that is tied to bowel movements or to a change in how often you go or what the stool looks like. Under the Rome IV criteria used by gastroenterologists worldwide, the pain occurs at least one day per week on average over three months, with symptoms starting at least six months ago.
For decades IBS was called a 'functional' disorder, medical shorthand for 'the tests are normal and we don't know why you hurt.' The Rome IV revision in 2016 deliberately renamed this family of conditions disorders of gut–brain interaction, because research had identified real mechanisms: disturbed motility, visceral hypersensitivity, altered signaling between the gut and the central nervous system, changes in the gut microbiome and immune activity, and altered processing of gut signals in the brain.
The rename matters for patients most of all. 'Nothing is wrong with you' was never true. What's wrong simply isn't visible on a colonoscopy. The problem lives in how the gut and nervous system talk to each other, which is a physiology problem, not a character flaw.
IBS is remarkably common. The Rome Foundation Global Epidemiology Study, covering over 73,000 adults across 33 countries, found that about 4.1% of adults meet strict Rome IV criteria for IBS (internet surveys; 1.5% in household surveys), and roughly 1 in 10 qualified under the older Rome III definition. More than 40% of people worldwide met criteria for at least one disorder of gut–brain interaction.
The core symptoms are abdominal pain or cramping, often relieved or worsened by a bowel movement, together with bloating, gas, urgency, and a change in bowel habits. Symptoms typically flare and settle over time, and often track with meals, stress, sleep, and hormonal cycles.
IBS is divided into subtypes by the predominant stool pattern on symptomatic days, because the subtypes are treated differently:
| Subtype | Pattern | Common name |
|---|---|---|
| IBS-C | Mostly hard or lumpy stools | Constipation-predominant |
| IBS-D | Mostly loose or watery stools | Diarrhea-predominant |
| IBS-M | Both, alternating | Mixed |
| IBS-U | Doesn't clearly fit the others | Unclassified |
Two things IBS does not do: it does not cause visible inflammation or damage to the bowel, and it does not raise your risk of colorectal cancer or turn into inflammatory bowel disease. The suffering is real. The prognosis for the bowel itself is benign.
Your gut has its own extensive nervous system, sometimes called the 'second brain,' in constant two-way conversation with the brain via the vagus nerve, spinal pathways, hormones, and the immune system. In IBS, that conversation is turned up too loud in both directions.
None of this means IBS is 'in your head.' It means the head is part of the circuit, and a circuit can be retrained. That is why therapies that target the brain's processing of gut signals have some of the strongest evidence in IBS, as covered below, and why the general principle of retraining an oversensitive pain system applies here.
IBS causes miserable symptoms but does not damage the bowel. Certain symptoms fall outside the IBS pattern and should always prompt a medical evaluation, because they can signal inflammatory bowel disease, celiac disease, colorectal cancer, or other conditions that need specific treatment:
Red flags don't mean something is definitely wrong. They mean the 'diagnose by pattern, test sparingly' shortcut no longer applies and your doctor should look further. If any of these apply to you, see a clinician before treating symptoms as IBS.
IBS used to be a diagnosis of exclusion, with every other possibility ruled out first, often through years of testing. Modern guidelines have reversed that. The American College of Gastroenterology recommends a positive diagnostic strategy: if your symptoms match the Rome IV pattern, red flags are absent, and a few targeted tests are clear, IBS can be diagnosed confidently without an exhaustive workup, which gets you to effective treatment sooner.
What a typical evaluation includes:
A confident diagnosis is itself therapeutic: it ends the cycle of escalating tests, names the mechanism, and opens the door to treatments that actually target it.
There is no single cure, but there is a genuine toolbox, and most people improve substantially with a combination matched to their subtype. Treatment usually proceeds along three tracks that work well together: diet, medication, and brain-directed therapy.
The best-studied dietary approach is a low-FODMAP diet: a short elimination of certain fermentable carbohydrates, followed by structured reintroduction to find your specific triggers. The ACG and AGA both endorse a limited trial, ideally with a dietitian's guidance. Two cautions: it is a diagnostic diet, not a permanent one (long-term restriction can affect nutrition and the microbiome), and it helps some people but not everyone. Soluble fiber (such as psyllium) also has guideline support, particularly for constipation-predominant IBS.
Options depend on subtype: antispasmodics and peppermint oil for cramping; laxatives and secretagogues for IBS-C; antidiarrheals, bile-acid binders, or rifaximin for IBS-D; and low-dose tricyclic antidepressants for pain across subtypes, used here as gut–brain neuromodulators at doses below those used for depression. What works is individual, and any medication decision belongs with your prescriber. Never start or stop a medication on your own.
Because the pain of IBS runs through gut–brain signaling, therapies that retrain the brain's side of the loop are first-line options with real trial evidence, covered in detail in the next section. ACG guidelines explicitly recommend gut-directed psychotherapies for global IBS symptoms.
This is the part of IBS treatment most people have never been offered, and it has some of the strongest evidence in the field. These are not talk therapy for distress. They are structured programs that target the specific brain–gut circuits producing symptoms.
These therapies reduce the threat value of gut sensations, interrupt the vigilance–anxiety–symptom loop, and give the nervous system repeated experiences of safety in the body, which turns the amplifier down. It is the same retraining logic used for other sensitized-pain conditions, and the same principle behind modern chronic pain treatment and brain-retraining programs generally: change how the brain processes signals from the body, and the symptoms produced from those signals can change too.
Choosing a brain-directed therapy is not admitting your IBS is psychological. Randomized trials don't work on imaginary diseases. These treatments succeed precisely because IBS is a physical disorder of gut–brain signaling, and the brain half of that circuit is trainable.
Between formal treatments, the texture of daily life makes a measurable difference in a condition wired into the stress and alarm systems:
IBS also carries a social weight that deserves acknowledgment: bathroom logistics, cancelled plans, explaining an invisible illness. The strategies in living with chronic pain apply here: pacing, honest communication, and refusing to let a condition shrink your life more than it must.
See a clinician promptly if you have any of the red flags above: bleeding, unintended weight loss, nighttime symptoms, anemia, fever, new symptoms after 50, or a family history of colorectal cancer, IBD, or celiac disease. Those need evaluation before any IBS label is applied.
Beyond red flags, it's worth seeing a doctor when symptoms are frequent enough to plan your life around, when you've never had a proper diagnosis, or when you've been told 'it's just IBS' and handed nothing else. A modern workup is brief, and a confirmed diagnosis unlocks subtype-specific treatment.
If you are diagnosed with IBS, ask specifically about the full toolbox: a dietitian-guided low-FODMAP trial, subtype-appropriate medications, and gut-directed hypnotherapy or CBT. Many patients are never told the brain-directed options exist, despite guideline support. If your IBS travels with other pain conditions like fibromyalgia or pelvic pain, that pattern itself is a clue that central sensitization is part of your picture, and our neuroplastic pain quiz can help you explore whether that fits.
IBS is entirely real. It is classified as a disorder of gut–brain interaction, with measurable mechanisms: heightened gut sensitivity, altered motility, and amplified pain processing in the nervous system. Nothing about that is imaginary.
The confusion comes from normal test results. Tests being normal means the problem isn't structural damage, not that there's no problem. The brain's involvement makes IBS more treatable, not less legitimate: it's why brain-directed therapies succeed in randomized trials.
IBS is coded under K58, subdivided by subtype: K58.0 for IBS with diarrhea, K58.1 for IBS with constipation, K58.2 for mixed IBS, and K58.9 for IBS without diarrhea or unspecified. Coding is your clinician's call. This is here so your paperwork makes sense.
Despite similar acronyms, they are different conditions. IBD, inflammatory bowel disease, means Crohn's disease and ulcerative colitis. It involves visible inflammation and damage to the bowel, detectable on colonoscopy and lab tests, and treated with anti-inflammatory and immune-targeting medication.
IBS involves no visible damage. The problem is oversensitive signaling between gut and brain. IBS does not turn into IBD, though the two can coexist. Red-flag symptoms like bleeding, weight loss, or nighttime diarrhea point away from IBS and should always be evaluated.
No. It's a tool, not a cure. A short low-FODMAP elimination followed by structured reintroduction helps many people identify specific food triggers, and both ACG and AGA guidance support trying it, ideally with a dietitian.
It should not become a permanent, ever-narrowing diet: long-term restriction can affect nutrition and the gut microbiome, and escalating food fear can itself amplify symptoms. If it doesn't help within a structured trial, the answer is a different tool, not more restriction.
Gut-directed hypnotherapy is one of the better-evidenced IBS treatments. In the 354-patient IMAGINE randomized trial, both individual and group hypnotherapy produced adequate relief lasting nine months after treatment, and meta-analyses of psychological therapies for IBS find them efficacious overall.
It is a specific, structured protocol targeting gut sensation and the gut–brain loop, not stage hypnosis and not generic relaxation. Availability is the main barrier. Ask a gastroenterologist or GI psychologist about in-person or validated digital programs.
Common triggers include specific foods (highly individual, often fermentable carbohydrates), large or rushed meals, stress and anticipatory anxiety, poor sleep, menstrual cycles, and gastrointestinal infections. Many people notice symptoms rise with life stress even when diet is unchanged.
That pattern isn't a sign of weakness. It's the gut–brain axis working as designed, with the dial set too high. Triggers are useful data: they show which inputs your treatment plan should target, from diet strategy to stress-response training.
No. IBS does not damage the bowel, cause visible inflammation, or increase the risk of colorectal cancer, and it doesn't shorten life expectancy. That is genuinely reassuring, but it is also why red flags matter: symptoms like rectal bleeding, weight loss, anemia, or nighttime symptoms fall outside the IBS pattern and need evaluation for other causes, on a normal screening schedule appropriate to your age and family history.
Talk with our care team about your pain, your history, and whether KVET™ is right for you. Free, and from the comfort of home.